Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DawaFast
AddedFeb 18, 2024
UpdatedJun 18, 2026
DawaFast

DawaFast

Dawafast: A Riyadh-based pharmaceutical firm offering online pharmacy services.

HQ
Riyadh, Riyadh Province, SA
Founded
2020
Accelerator
Techstars logoTechstars: The Riyadh2021
Overview
Compare
Fundraising
Employees
Website

DawaFast, founded in Riyadh, Saudi Arabia, is a pharmaceutical manufacturing firm with a core mission to enhance healthcare accessibility through technology. The company's vision is to streamline the pharmaceutical supply chain and provide convenient, reliable access to medications. DawaFast offers an online pharmacy shopping platform, enabling customers to purchase a wide range of pharmaceutical products from the comfort of their homes. The firm primarily focuses on the Saudi Arabian market, aiming to meet the growing demand for efficient and accessible healthcare solutions.

Notable figures associated with DawaFast include key industry experts and investors who have significantly contributed to its growth. The company has achieved considerable milestones, including a robust online presence and a loyal customer base. DawaFast's impact is evident in its ability to improve medication accessibility and convenience for its users, positioning itself as a vital player in the region's healthcare landscape.

DawaFast - Similar Companies

Dawah Pharmaceuticals logo

Dawah Pharmaceuticals

dawahpharma.com

GeniusRx logo

GeniusRx

geniusrx.com

Pills2Me logo

Pills2Me

pills2me.com

Sanvivo logo

Sanvivo

sanvivo.eu

Honeybee Health logo

Honeybee Health

honeybeehealth.com

Dr.Online logo

Dr.Online

dronline.com

DiRx logo

DiRx

dirxhealth.com

KemNet logo

KemNet

kemnet.ca

Qwark logo

Qwark

qwarkhealth.com

Health Haven Rx logo

Health Haven Rx

healthhavenrx.com

InStockRx logo

InStockRx

instockrx.com

Rx Delivered Now logo

Rx Delivered Now

rxdeliverednow.com

NimbleRx logo

NimbleRx

nimblerx.com

Remedial Health logo

Remedial Health

remedial.health

Mednow.ca logo

Mednow.ca

mednow.ca

DawaFast - Quick Facts

Who are DawaFast's competitors?

Companies similar to DawaFast include Dawah Pharmaceuticals, GeniusRx, Pills2Me and Sanvivo.

When was DawaFast founded?

DawaFast was founded in 2020.

Where is DawaFast's headquarters located?

DawaFast's headquarters is located in Riyadh, Riyadh Province, SA.

When was DawaFast's last funding round?

DawaFast's most recent funding round was for $120k (USD) in March 2022.

How much has DawaFast raised to-date?

As of Mar 25, 2022, DawaFast has raised a total of $120k (USD).

How many employees does DawaFast have?

DawaFast has 14 employees as of Feb 4, 2024.

DawaFast - Classification

Industry
  • Retail
Technology
  • Ecommerce
Geographic Exposure
  • Saudi Arabia
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Pharmaceuticals
  • Pharmacy
Tags
  • SaaS
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 11 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 5900Miscellaneous Retail
  • 2830Drugs
  • 5910Drug Stores And Proprietary Stores
  • 2834Pharmaceutical Preparations